Texas Oncology, P.A.

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Bladder cancer1 trial
• Chronic myeloid leukaemia1 trial
• Colorectal cancer1 trial
• Gastric and oesophageal cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Multiple myeloma1 trial
• Neuroendocrine tumours1 trial
• Sarcoma1 trial
• Thyroid cancer1 trial

Phase

• Phase 1/22 trials
• Phase 22 trials
• Phase 31 trial

Status

• Active, not recruiting3 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• US Oncology Research2 trials
• Hutchmed1 trial
• Janssen Research & Development, LLC1 trial
• Novartis Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

  NCT04782687· Phase 2· US Oncology Research· Source

• Active, not recruiting

  A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer

  NCT03473743· Phase 1/2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  PhII ICb With/Without Erbitux in MBC Pts

  NCT00248287· Phase 2· US Oncology Research· Source

Closed trials

• Completed

  Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

  NCT04666259· Phase 3· Novartis Pharmaceuticals· Source

• Terminated

  Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

  NCT04579757· Phase 1/2· Hutchmed· Source